Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 599

1.

Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.

Kaufer DI, Borson S, Kershaw P, Sadik K.

CNS Spectr. 2005 Jun;10(6):481-8. Review.

PMID:
15908902
2.

[Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].

Guetin S, Portet F, Picot MC, Defez C, Pose C, Blayac JP, Touchon J.

Encephale. 2009 Feb;35(1):57-65. doi: 10.1016/j.encep.2007.10.009. Epub 2008 Feb 20. French.

PMID:
19250995
3.

The effects of galantamine treatment on caregiver time in Alzheimer's disease.

Sano M, Wilcock GK, van Baelen B, Kavanagh S.

Int J Geriatr Psychiatry. 2003 Oct;18(10):942-50.

PMID:
14533127
4.

Predicting caregiver burden and depression in Alzheimer's disease.

Clyburn LD, Stones MJ, Hadjistavropoulos T, Tuokko H.

J Gerontol B Psychol Sci Soc Sci. 2000 Jan;55(1):S2-13.

PMID:
10728125
5.

The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial.

Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF, Dubois B.

J Am Geriatr Soc. 2000 Mar;48(3):268-74.

PMID:
10733052
6.

Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.

Monsch AU, Giannakopoulos P; GAL-SUI Study Group.

Curr Med Res Opin. 2004 Jun;20(6):931-8.

PMID:
15200752
7.

Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study.

Suh GH, Jung HY, Lee CU, Choi S; Korean Galantamine Study Group.

J Korean Med Sci. 2008 Feb;23(1):10-7. doi: 10.3346/jkms.2008.23.1.10.

8.

Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers.

Pang FC, Chow TW, Cummings JL, Leung VP, Chiu HF, Lam LC, Chen QL, Tai CT, Chen LW, Wang SJ, Fuh JL.

Int J Geriatr Psychiatry. 2002 Jan;17(1):29-34.

PMID:
11802227
9.

The needs of the caregiver in the long-term treatment of Alzheimer disease.

Bullock R.

Alzheimer Dis Assoc Disord. 2004 Apr-Jun;18 Suppl 1:S17-23. Review.

PMID:
15249844
10.
11.

Effects of the Medicare Alzheimer's Disease Demonstration on caregiver burden and depression.

Newcomer R, Yordi C, DuNah R, Fox P, Wilkinson A.

Health Serv Res. 1999 Aug;34(3):669-89.

12.

The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.

Davis KL, Marin DB, Kane R, Patrick D, Peskind ER, Raskind MA, Puder KL.

Int J Geriatr Psychiatry. 1997 Oct;12(10):978-88.

PMID:
9395929
13.

Navigating patients and caregivers through the course of Alzheimer's disease.

Aupperle PM.

J Clin Psychiatry. 2006;67 Suppl 3:8-14; quiz 23. Review.

PMID:
16649846
14.

Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.

Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S; GAL-INT-28 Study Group.

Curr Med Res Opin. 2005 Sep;21(9):1423-9.

PMID:
16197661
15.

Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis.

Lingler JH, Martire LM, Schulz R.

J Am Geriatr Soc. 2005 Jun;53(6):983-90. Review.

PMID:
15935021
16.

Caring for a relative with dementia: family caregiver burden.

Papastavrou E, Kalokerinou A, Papacostas SS, Tsangari H, Sourtzi P.

J Adv Nurs. 2007 Jun;58(5):446-57. Epub 2007 Apr 17.

PMID:
17442030
17.

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, Schneider L, Takeda M, Tariot P, Wilkinson D.

Int J Geriatr Psychiatry. 2001 Jul;16(7):653-66. Review.

PMID:
11466744
18.

[Burden of caregivers caring for persons with dementia].

Raś P, Opala G.

Wiad Lek. 2001;54(1-2):94-100. Review. Polish.

PMID:
11344708
19.

Galantamine: use in Alzheimer's disease and related disorders.

Bullock R.

Expert Rev Neurother. 2004 Mar;4(2):153-63. Review.

PMID:
15853556
20.

The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease.

Marin DB, Dugue M, Schmeidler J, Santoro J, Neugroschl J, Zaklad G, Brickman A, Schnur E, Hoblyn J, Davis KL.

Int J Geriatr Psychiatry. 2000 Aug;15(8):680-6.

PMID:
10960880

Supplemental Content

Support Center